Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

December 15, 2023

Study Completion Date

December 15, 2023

Conditions
Pain
Interventions
DRUG

Active CBD/THC Dose 1

Subjects will self-administer the assigned study medication daily at home after pickup and will be tested using medication compliance procedures. Subjects will visit the center 2 times in the 7-day period on days 1 and 7 for blood draws to assess medication compliance.

DRUG

Active CBD/THC Dose 2

Subjects will self-administer the assigned study medication daily at home after pickup and will be tested using medication compliance procedures. Subjects will visit the center 2 times in the 7-day period on days 1 and 7 for blood draws to assess medication compliance.

DRUG

matched placebo comparator

Subjects will self-administer the assigned study medication daily at home after pickup and will be tested using medication compliance procedures. Subjects will visit the center 2 times in the 7-day period on days 1 and 7 for blood draws to assess medication compliance.

Trial Locations (1)

06519

The Yale Stress Center: Yale University, New Haven

Sponsors
All Listed Sponsors
collaborator

Connecticut Pharmaceutical Solutions

UNKNOWN

lead

Yale University

OTHER